Merck & Co Inc (NYSE:MRK)
$ 129.55 -0.83 (-0.64%) Market Cap: 328.13 Bil Enterprise Value: 358.83 Bil PE Ratio: 143.94 PB Ratio: 8.13 GF Score: 85/100

Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 09:30PM GMT
Release Date Price: $81.05 (+2.37%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott from JPMorgan. And I'm pleased today to be hosting a fireside chat with Merck management. We can't be in person at the Westin, but we've tried to recreate the best of that here at JPMorgan.

But from Merck, we have Ken Frazier, the company's Chairman and CEO; as well as Rob Davis, the company's CFO; and Dean Li, who is newly appointed President of Merck Research Labs. So thanks, everyone, for joining us today.

Questions & Answers

Christopher Thomas Schott;Kenneth C. Frazier
JPMorgan Chase & Co, Research Division - Senior Analyst;Merck & Co., Inc. - Chairman, President &amp

So Ken, maybe just a question to open up with. Obviously, 2020 was an extraordinary year for everybody. But as we turn the page to 2021, can you just kick off with some opening comments in terms of key priorities for Merck as we enter the year? And just how you're thinking about the business for the year?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot